Doctor characteristics may influence prostate cancer treatment
Whether a man's low-risk prostate cancer gets treated with surveillance, surgery or another method may have more to do with his doctor than his health, according to a new study. Urologists who had been practicing for more years and those who treated more advanced cases of the disease were less likely to use a wait-and-see approach to manage low-risk prostate cancer, researchers found. "The physician a patient sees can influence their treatment fate," said Dr. Karen Hoffman. "Physicians play an important role in whether or not men with low-risk prostate cancer are managed with observation or treatment."
- Governors Push to Expand Role of PAs, Telemedicine
- 3 More Pioneer ACOs Say They Will Quit
- Telemetry Overuse Cost Health System $4.8 Million in One Year
- Why Open Payments Irks Physicians
- Ebola in the U.S.: Reason to Fear, to Hope, to Prepare
- IV Fluids Shortage Continues
- Difficult Patients: It's Not Them, It's You, Doctor
- Overcoming a Payer Mix 'Nightmare'
- Employee Engagement: Make It Meaningful
- Proton Beam Therapy Center Closure Illuminates Costs